Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Vertex Pharmaceuticals Inc (VRTX)

Healthcare Biotechnology
477.10 $
-1.0% vs. previous close
Closing price · As of: 31. Jul 2026

Vertex Pharmaceuticals Inc (VRTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Revenue" came in at 2,987 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Income Statement VRTX
Tick rows to compare them in a chart (up to 4) Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 LTM
2,493 2,484 2,518 2,687 2,646 2,772 2,912 2,770 2,965 3,076 3,227 2,987 12,255
309 319 368 343 372 393 423 363 408 415 466 393 1,681
2,185 2,165 2,150 2,345 2,274 2,379 2,489 2,407 2,557 2,662 2,761 2,594 10,574
896 862 1,352 866 5,416 876 999 980 978 1,032 974 962 3,946
262 264 369 343 372 372 378 396 425 445 487 494 1,850
1,159 1,126 1,161 1,209 5,788 1,263 1,463 1,777 1,406 1,475 1,461 1,456 5,798
1,026 1,038 989 1,140 -3,515 1,116 1,026 630 1,151 1,186 1,300 1,138 4,776
11 11 11 10 9.9 7.5 2.8 3.0 3.7 3.3 3.3
1,162 1,179 1,148 1,279 -3,391 1,224 1,137 730 1,283 1,299 1,331 1,253 5,166
246 144 179 180 202 179 224 84 250 216 140 222 827
916 1,035 969 1,100 -3,594 1,045 913 646 1,033 1,083 1,191 1,031 4,338
1,214 1,232 1,217 1,343 -3,327 1,285 1,184 782 1,338 1,356 1,387 1,309 5,391

LTM = last twelve months (sum of the four most recent quarters).

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?